Soros Fund Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-18,300
Closed -$689K 182
2017
Q3
$689K Buy
+18,300
New +$689K 0.02% 132
2017
Q2
Sell
-8,900
Closed -$306K 189
2017
Q1
$306K Buy
+8,900
New +$306K 0.01% 191
2016
Q4
Sell
-17,645
Closed -$561K 193
2016
Q3
$561K Buy
+17,645
New +$561K 0.01% 148